-
WNT5a/GSK3/β-Catenin Control of Muscle FAPs
2026-09-03
This study identifies the WNT5a/GSK3/β-catenin axis as a previously underappreciated regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, network modeling, and transcriptomic datasets, the authors connect β-catenin stabilization with reduced fat accumulation and improved FAP support of muscle regeneration.
-
Panobinostat (LBH589): Reliable Cell Assays
2026-09-03
This scenario-based guide explains how Panobinostat (LBH589), SKU A8178, can support more interpretable viability, proliferation, and apoptosis experiments. It combines product-specific handling data with current evidence on HDAC biology and RNA polymerase II-linked cell death signaling.
-
BML-277: Mapping the Chk2–cGAS Checkpoint
2026-09-02
BML-277 is a potent Chk2 inhibitor for dissecting DNA damage signaling beyond simple kinase readouts. This article explains how to use it to test the CHK2–cGAS–TRIM41 pathway while separating biochemical inhibition, T-cell radioprotection, and L1 retrotransposition phenotypes.
-
Tin Mesoporphyrin IX: HO Assay Strategy
2026-09-02
Tin Mesoporphyrin IX (chloride) is a nanomolar competitive heme oxygenase inhibitor for mechanistic studies of heme catabolism, redox biology, and metabolic disease research. This article shows how to use C5606 to distinguish HO-dependent effects from downstream antiviral and cellular phenotypes.
-
HotStart Universal 2X Green qPCR Master Mix Workflow
2026-09-01
Build a reproducible RT-qPCR workflow for diet-intervention studies, including finishing-pig assays that connect tissue gene expression with meat-quality and microbiota findings. This guide combines hot-start specificity, Green I fluorescence, ROX normalization, melt-curve verification, and practical troubleshooting for reliable gene expression quantification.
-
ATP Solution for mRNA-LNP Research
2026-09-01
ATP Solution (100 mM) supports reproducible kinase, transcription, ligation, and phosphorylation workflows that underpin mRNA-LNP development. This guide connects precise ATP handling with the localized p21 mRNA-LNP strategy reported for bladder cancer while separating upstream assay support from therapeutic evidence.
-
LDH Cytotoxicity Assay Kit: Workflow & QC
2026-08-31
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive colorimetric approach for cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is intended for comparative in vitro studies, not for assigning a specific death pathway, in vivo testing, or clinical diagnosis.
-
Dabigatran Etexilate: Oral Thrombin Inhibition
2026-08-31
This clinical review examines dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its rapid, predictable anticoagulant activity and reduced dependence on INR monitoring. Its prodrug conversion, renal clearance, efficacy across thromboembolic settings, and bleeding-related limitations remain central to interpreting its clinical role.
-
Humanized Mice Clarify HD56 Prodrug Exposure
2026-08-30
The 2025 reference study shows that humanized-liver mice can resolve species-dependent metabolism of the CES-activated prodrug HD56 and improve prediction of its conversion to HD561. Its strong in vivo–in vitro correlation highlights why human-relevant metabolic models are valuable when conventional animal data are difficult to translate.
-
Graphene-Induced Apoptosis in Melanoma Cells
2026-08-29
The reference study shows that graphene film suppresses B16F10 melanoma-cell proliferation while engaging intrinsic apoptosis, oxidative stress, and G0/G1 cell-cycle arrest. Its combination of transcriptomics, biochemical readouts, and caspase-inhibitor rescue experiments provides a useful framework for interpreting how nanomaterial exposure reshapes melanoma cell-death programs.
-
RHEB Neddylation Links UBE2F to Liver Tumorigenesis
2026-08-28
The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the functionally important modification to K169. By connecting this modification with lysosomal RHEB localization, GTP binding, mTORC1 activation, and PTEN-loss-driven liver tumorigenesis, the work establishes a mechanistic link between neddylation and oncogenic nutrient signaling.
-
CGRP/SP–Piezo2 Axis in Trigeminal Neuralgia
2026-08-28
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and in vitro experiments place PKC, cAMP, extracellular ATP, ERK1/2, and p38 MAPK within a compartment-specific TG neuron–Merkel cell mechanism that may clarify how touch becomes painful in trigeminal neuralgia.
-
HSP90 Inhibition Rewires Lung Adenocarcinoma Proteomes
2026-08-27
This study used two-dimensional electrophoresis and mass spectrometry to map how pharmacological HSP90 disruption changes the proteome of lung adenocarcinoma cells. Its identification of 254 differentially expressed proteins, including eIF3i and citrate synthase, connects chaperone inhibition with apoptosis, serine-glycine metabolism, and the tricarboxylic acid cycle while providing candidate response biomarkers.
-
FLAG tag Peptide: Assay Design for NMD Biology
2026-08-27
Discover how the FLAG tag Peptide and DYKDDDDK peptide support controlled recombinant protein detection, purification, and mechanistic studies of the Smg5–Hnrnpl–Mag axis. This guide focuses on assay architecture, interpretation, and limitations rather than a conventional product overview.
-
Tetrazolium (chloride) for Viability Assays
2026-08-26
Tetrazolium (chloride), also called Tetrazolium Red or TTC, converts mitochondrial dehydrogenase activity into a visible red formazan signal for cell and tissue analysis. Its combination of spectrophotometric quantification and spatial staining makes it especially useful for ischemic injury research, including stroke and cardiac infarction models.